Best solution for Feline Blood Typing
Bioguard are glad to introduce our new development products “Feline Blood Typing Test” This product had been tested by many cats with different breed and blood typing. We got satisfaction and only positive feedback from all those who have tried the product. Now we launch it officially. Veterinary clinics could have better choice for testing feline blood typing. We are pleased to invite clinics and veterinarians to try our new Feline Blood Typing Test. If you are interested and want to use our products, please contact your local distributor or mail to service@biogurd.com.tw . We will inform you about more details of it.
Bioguard is very happy to announce our new diagnostic product Babesia gibsoni Ab Test
A rapid and cost‐effective diagnostic test would increase the feasibility of mass screening of dogs for infection and monitoring treatment efficacy in B. gibsoni‐infected dogs.
Bioguard Blood Pathogen Test: An appropriate blood parasite pathogen testing for canine health check
Bioguard Blood Pathogen Test available for detection of the antigen or antibody response to canine blood pathogens, Dirofilaria immitis (CHW), Ehrlichia canis, Anaplasma platy and Borrelia burgdorferi (Lyme disease) have the advantages of being rapid and inexpensive, and the potential for operator error with most assays is small.
Bioguard wins the Best New Release of 2020 in WESAVC on-line show
Bioguard was proud to participate 2020 in WESAVC on-line show and introdeced our new launched products. Our Bioguard Canine Babesia gibsoni Ab Test & Bioguard Feline Blood Typing Kit win the Best New Release of 2020 in WESAVC on-line show.
Bioguard Corporation to officially announce the renaming of the Canine Blood Pathogen test, CDV/CAV/CIV test, and CPV/CCV/Giardia test to Vlabs 4X, Vlabs 3RX,and Vlabs 3DX.
Bioguard Corporation is proud and delighted to announce that we are changing our “Canine Blood Pathogen name to Vlabs 4X”, “CDV/CAV/CIV test to Vlabs 3RX”, CPV/CCV/Giardia to Vlabs 3DX. The name change is a result of an effort designed to be more compatible with our marketing strategy. In the spirit of renaming some of our products, it is important to let you know that it will not affect or delay any current or future orders. However, this letter is intended to offer notice that our Canine Blood Pathogen, CDV/CAV/CIV, CPV/CCV/Giardia, to be renamed in all invoicing, packaging, and related documents after October 5, 2020.
Bioguard Feline Blood Typing Kit does not concern about Ab-Ag interaction
Highly match base on agglutination test Bioguard Feline Blood Typing Kit does not concern about Ab-Ag interaction and has an advantage in identifying cats with auto-hemagglutination and hemagglutination inhibition of blood. This additional pro can help veterinarians prevent blood transfusion that could cause complications in cats later on.
Bioguard Supports the 12th East and West Small Animal Clinical Veterinary Conference
The Bioguard sponsors the 12th East and West Small Animal Clinical Veterinary Conference as the event goes virtual on November 24-26, 2020. The event is one of the biggest conferences for small animal veterinary. It is yearly held in China, however, due to the pandemic, some of the invited lecturers from Taiwan will be giving their lectures virtually. The exhibition in China will still be held. With many participants who can’t travel to join the event, the virtual conference will be made available, in partnership with Bioguard Corporation.
Bioguard Will Launch New Biological indicators in 2021
Bioguard Corporation delighted to announce that we will launch new biological indicators for pets on this coming 2021. AGP, cPL, fPL and NT-proBNP will be the first wave to the market. We will continue to commit to our customers and provide more important indicator for diagnosis.
Bioguard is Upgrading its GMP Facility to Human Level
In the idea to bring better support to our customers in the international market, Bioguard is to upgrade its Manufacturing Practice (GMP) to the human level.
Bioguard Introduces the New Vscan Reader
Bioguard introduces the new Vscan reader, an innovative equipment developed by Bioguard to display and quickly interpret results with selection flexibility of Fluorescence and Colorimetric method. The Vscan reader will enable veterinarians to provide reliable on-site diagnosis and accurately perform Qualitative/Quantitative analysis of various items, such as SDMA, NT-proBNP, cPL, AGP, fPL and several others, that are very important diagnosis indicators for veterinarians.
